Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge

This publication has 30 references indexed in Scilit:

• The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys
  Vaccine, 1998
• Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model
  Vaccine, 1996
• Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers
  Vaccine, 1996
• Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis
  Vaccine, 1995
• The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
  Nature, 1995
• A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus
  Vaccine, 1994
• Pathogenesis of Dengue: Challenges to Molecular Biology
  Science, 1988
• Rapid focus reduction neutralization test of Japanese encephalitis virus in microtiter system
  Archiv für die gesamte Virusforschung, 1985
• Dengue Virus Type 2 Vaccine: Reactogenicity and Immunogenicity in Soldiers
  The Journal of Infectious Diseases, 1984
• Experimental Studies on Dengue: I. Isolation, Identification and Modification of the Virus
  The Journal of Infectious Diseases, 1952